Specificity of miRNA Processing Provided by Double-Stranded RNA Binding Domains
双链 RNA 结合域提供的 miRNA 加工特异性
基本信息
- 批准号:8160141
- 负责人:
- 金额:$ 27.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-09-01 至 2016-08-31
- 项目状态:已结题
- 来源:
- 关键词:AffinityAutoimmune DiseasesBackBasic ScienceBindingBiochemistryBioinformaticsBiological AssayC-terminalCardiovascular DiseasesCell Differentiation processCellsCharacteristicsClinical SciencesCommunicable DiseasesComplexDataDevelopmentDiabetes MellitusDouble-Stranded RNADouble-Stranded RNA Binding DomainEnzymesGene ExpressionHealthHereditary DiseaseHumanIndividualInsulinInterventionKnowledgeLinkLiteratureMediatingMediator of activation proteinMessenger RNAMicroRNAsMicroprocessorMolecularMolecular AbnormalityMolecular ChaperonesMolecular and Cellular BiologyNMR SpectroscopyNeurodegenerative DisordersOrganismOutcomePathway interactionsPositioning AttributePrevalenceProcessProductionProteinsRNARNA BindingRNA PrecursorsRNA ProcessingRNA-Protein InteractionReactionRecombinantsRecruitment ActivityRegulator GenesResearchResolutionRibonuclease IIIRibonucleoproteinsRoleSmall Interfering RNASmall RNASpecificityStimulusStructureTechniquesTertiary Protein StructureTestingTherapeuticTranslatingWorkbasecell growthendonucleaseheart metabolismhuman DICER1 proteinnovelprogramsprotein complexprotein protein interactionresearch studyresponsescaffoldsimulationstructural biologytumor progression
项目摘要
DESCRIPTION (provided by applicant): MicroRNA (miRNA) has emerged as a post-transcriptional regulator of gene expression impacting - among other factors - cell growth and differentiation, and the progression of multiple genetic diseases. miRNA processing in the cell involves two ribonucleoprotein complexes composed of RNase III enzymes and double-stranded RNA binding domain (dsRBD) chaperones that work together to achieve two highly specific endonuclease cleavages. The central hypothesis of this proposal is that the specificity inherent to the miRNA processing activity of these multi-protein complexes is a direct result of dsRBD interactions: the specific recognition of the miRNA precursors by the dsRBDs in the complexes and the unique juxtaposition of the multiple dsRBDs. There are at least ten dsRBDs involved in miRNA production: two in DGCR8, one in Drosha, one in Dicer, three in TRBP, and three in PACT. Bioinformatics approaches have vastly increased our knowledge of miRNA prevalence and function, and cellular and molecular biology approaches have provided a general, but powerful, overview of miRNA biochemistry and function. Structural biology techniques have been extensively applied to the proteins involved in processing small interfering RNA (siRNA) in unicellular organisms, and the results have been extrapolated to partially explain miRNA processing in multicellular organisms. However, only the second endonuclease-mediated maturation step necessary for production of functional miRNA is shared with the simpler siRNA pathway, where the mode of function is also mechanistically distinct. Thus, much remains to be worked out for miRNA maturation. This project will take a holistic structural biology based approach, aiming to establish the molecular mechanism of miRNA processing by both the Microprocessor complex - unique to miRNA processing - and the complexes shared between the miRNA and siRNA pathways. The first aim of the project is to provide atomic resolution structures for each of the dsRBDs involved in miRNA processing, which have not previously had their structures determined, to define the conformational dynamics of each by NMR spectroscopy, and to quantify the intrinsic RNA binding affinity of each dsRBD in isolation. In the second aim, the role of the dsRBDs from the RNase III endonucleases Drosha and Dicer in providing specificity to the cleavage reactions they catalyze will be explored through binding assays and NMR spectroscopy. Three of the five proteins to be studied contain more than one dsRBD - as do both of the ribonucleoprotein complexes composed by them - and so aim 3 will seek to define the role of cooperative interactions among the dsRBDs in yielding affinity and specificity for binding to miRNA precursors. The full molecular understanding of miRNA processing proposed herein will allow novel entry points for targeted manipulation of miRNA expression, which may have broad impacts on both basic and clinical science.
PUBLIC HEALTH RELEVANCE: Therapeutic administration of small RNA molecules for intervention in both genetic and infectious disease has recently emerged as a broadly effective strategy. Naturally occurring microRNAs control gene expression and their function has been linked to the progression of cancer, diabetes, cardiovascular disease, neurodegenerative disease, and autoimmune disease - leading to the hope that therapeutic manipulation of their expression may yield novel entry points for treatments that are distinct from those created by introducing synthetic RNA into cells. This proposal aims to create detailed molecular understanding of the natural microRNA maturation process and thus provide rational direction to efforts aimed at employing this pathway for health intervention.
描述(由申请人提供):MicroRNA (miRNA)已成为基因表达的转录后调节剂,影响细胞生长和分化以及多种遗传疾病的进展。细胞中的miRNA加工涉及两种由RNase III酶和双链RNA结合域(dsRBD)伴侣组成的核糖核蛋白复合物,它们共同作用以实现两种高度特异性的内切酶切割。该建议的中心假设是,这些多蛋白复合物的miRNA加工活性固有的特异性是dsRBD相互作用的直接结果:复合物中的dsRBD对miRNA前体的特异性识别以及多个dsRBD的独特并立。至少有10个dsrbd参与miRNA的产生:2个在DGCR8中,1个在Drosha中,1个在Dicer中,3个在TRBP中,3个在PACT中。生物信息学方法极大地增加了我们对miRNA流行和功能的了解,细胞和分子生物学方法提供了miRNA生物化学和功能的一般但强大的概述。结构生物学技术已被广泛应用于单细胞生物中参与小干扰RNA (siRNA)加工的蛋白质,其结果已被推断为部分解释多细胞生物中miRNA加工的原因。然而,只有产生功能性miRNA所需的第二个内切酶介导的成熟步骤与更简单的siRNA途径共享,其功能模式在机制上也是不同的。因此,对于miRNA的成熟还有很多工作要做。该项目将采用基于整体结构生物学的方法,旨在通过miRNA加工特有的微处理器复合物以及miRNA和siRNA途径之间共享的复合物建立miRNA加工的分子机制。该项目的第一个目标是为参与miRNA加工的每个dsRBD提供原子分辨率结构,这些结构以前没有确定过,通过核磁共振波谱确定每个dsRBD的构象动力学,并量化每个dsRBD的内在RNA结合亲和力。在第二个目标中,RNase III内切酶Drosha和Dicer的dsrbd在提供其催化的裂解反应特异性方面的作用将通过结合试验和核磁共振波谱来探索。要研究的五种蛋白质中有三种含有不止一种dsRBD——由它们组成的两种核糖核蛋白复合物也是如此——因此,目的3将试图确定dsRBD之间的合作相互作用在产生与miRNA前体结合的亲和力和特异性方面的作用。本文提出的对miRNA加工过程的全面分子理解将为靶向操纵miRNA表达提供新的切入点,这可能对基础和临床科学产生广泛的影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Scott A Showalter其他文献
Scott A Showalter的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Scott A Showalter', 18)}}的其他基金
Pilot Studies of PAX3-FOXO1 Fusions Proteins in Alveolar Rhabdomyosarcoma
PAX3-FOXO1 融合蛋白在肺泡横纹肌肉瘤中的初步研究
- 批准号:
10726763 - 财政年份:2023
- 资助金额:
$ 27.5万 - 项目类别:
Structure and Mechanism of Transcription Factors in Pancreatic Beta Cells
胰腺β细胞转录因子的结构和机制
- 批准号:
10200033 - 财政年份:2019
- 资助金额:
$ 27.5万 - 项目类别:
Structure and Mechanism of Transcription Factors in Pancreatic Beta Cells
胰腺β细胞转录因子的结构和机制
- 批准号:
9764588 - 财政年份:2019
- 资助金额:
$ 27.5万 - 项目类别:
Specificity of miRNA Processing Provided by Double-Stranded RNA Binding Domains
双链 RNA 结合域提供的 miRNA 加工特异性
- 批准号:
8415995 - 财政年份:2011
- 资助金额:
$ 27.5万 - 项目类别:
Specificity of miRNA Processing Provided by Double-Stranded RNA Binding Domains
双链 RNA 结合域提供的 miRNA 加工特异性
- 批准号:
8323318 - 财政年份:2011
- 资助金额:
$ 27.5万 - 项目类别:
ASSESSMENT OF MULTI-MICROSECOND SIMULATIONS OF INTRINSICALLY DISORDERED PROTEIN
内在无序蛋白质的多微秒模拟评估
- 批准号:
8364372 - 财政年份:2011
- 资助金额:
$ 27.5万 - 项目类别:
Specificity of miRNA Processing Provided by Double-Stranded RNA Binding Domains
双链 RNA 结合域提供的 miRNA 加工特异性
- 批准号:
8727059 - 财政年份:2011
- 资助金额:
$ 27.5万 - 项目类别:
Specificity of miRNA Processing Provided by Double-Stranded RNA Binding Domains
双链 RNA 结合域提供的 miRNA 加工特异性
- 批准号:
8537952 - 财政年份:2011
- 资助金额:
$ 27.5万 - 项目类别:
NMR/MD Studies of Human MDM2 Interaction with P53
人类 MDM2 与 P53 相互作用的 NMR/MD 研究
- 批准号:
7085339 - 财政年份:2005
- 资助金额:
$ 27.5万 - 项目类别:
NMR/MD Studies of Human MDM2 Interaction with P53
人类 MDM2 与 P53 相互作用的 NMR/MD 研究
- 批准号:
7000011 - 财政年份:2005
- 资助金额:
$ 27.5万 - 项目类别:
相似国自然基金
Autoimmune diseases therapies: variations on the microbiome in rheumatoid arthritis
- 批准号:31171277
- 批准年份:2011
- 资助金额:60.0 万元
- 项目类别:面上项目
相似海外基金
Autoantibodies and antibody-secreting cells in neurological autoimmune diseases: from biology to therapy
神经性自身免疫性疾病中的自身抗体和抗体分泌细胞:从生物学到治疗
- 批准号:
479128 - 财政年份:2023
- 资助金额:
$ 27.5万 - 项目类别:
Operating Grants
Effects of maternal immune activation on autoimmune diseases in offsprings
母体免疫激活对后代自身免疫性疾病的影响
- 批准号:
23H02155 - 财政年份:2023
- 资助金额:
$ 27.5万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
IPP: AUTOIMMUNE DISEASES STATISTICAL AND CLINICAL COORDINATING CENTER (ADSCCC)
IPP:自身免疫性疾病统计和临床协调中心 (ADSCCC)
- 批准号:
10788032 - 财政年份:2023
- 资助金额:
$ 27.5万 - 项目类别:
Biomarkers of vascular endothelial dysfunction in systemic autoimmune diseases: analysis of circulating microRNAs
系统性自身免疫性疾病中血管内皮功能障碍的生物标志物:循环 microRNA 分析
- 批准号:
23K14742 - 财政年份:2023
- 资助金额:
$ 27.5万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
NOVEL HUMORAL AND CELLULAR BIOMARKERS OF AUTOIMMUNE DISEASES CAUSED BY IMMUNOTHERAPY
免疫治疗引起的自身免疫性疾病的新型体液和细胞生物标志物
- 批准号:
10593224 - 财政年份:2023
- 资助金额:
$ 27.5万 - 项目类别:
Structural mechanisms of autoimmune diseases targeting cys-loop receptors
针对半胱氨酸环受体的自身免疫性疾病的结构机制
- 批准号:
10864719 - 财政年份:2023
- 资助金额:
$ 27.5万 - 项目类别:
Developing non-immunosuppressive immune-based therapeutics for targeted treatment of autoimmune diseases
开发非免疫抑制性免疫疗法来靶向治疗自身免疫性疾病
- 批准号:
10586562 - 财政年份:2023
- 资助金额:
$ 27.5万 - 项目类别:
Regulation of autoimmune diseases by PTPN22 phosphatase
PTPN22磷酸酶对自身免疫性疾病的调节
- 批准号:
23K06589 - 财政年份:2023
- 资助金额:
$ 27.5万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Decipher and target GABA metabolism and GABA receptor-mediated signaling in autoimmune diseases
破译并靶向自身免疫性疾病中的 GABA 代谢和 GABA 受体介导的信号传导
- 批准号:
10623380 - 财政年份:2023
- 资助金额:
$ 27.5万 - 项目类别:
Targeting the long isoform of the prolactin receptor to treat autoimmune diseases and B-cell malignancies
靶向催乳素受体的长亚型来治疗自身免疫性疾病和 B 细胞恶性肿瘤
- 批准号:
10735148 - 财政年份:2023
- 资助金额:
$ 27.5万 - 项目类别: